GE HealthCare announces a $35 million expansion to its existing agreement with the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services. The cost share agreement is funded primarily by BARDA and builds on a program launched in October 2023.
The expanded scope supports development of AI powered ultrasound tools and new platforms aimed at trauma assessment and mass casualty preparedness. The solutions are designed to improve diagnostic speed and reduce reliance on highly specialized operators, including support for non expert users.
New capabilities focus on lung and pleural pathology assessment and detection of intra abdominal injuries. GE HealthCare also develops point of care ultrasound systems designed for demanding settings such as emergency departments, field hospitals and medical transport.
The program includes collaboration with clinicians and medical evaluation sites to generate clinical evidence and guide development based on real world feedback.
Leave a comment